Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines

Differentiation-inducing factor-1 (DIF-1), a morphogen for Dictyostelium discoideum, inhibits the proliferation of human cancer cell lines by suppressing the Wnt/β-catenin signaling pathway. In this study, we examined the effect of DIF-1 on c-Myc, a target gene product of the Wnt/β-catenin signaling...

Full description

Bibliographic Details
Main Authors: Kentaro Jingushi, Toshihisa Nakamura, Fumi Takahashi-Yanaga, Etsuko Matsuzaki, Yutaka Watanabe, Tatsuya Yoshihara, Sachio Morimoto, Toshiyuki Sasaguri
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861319303858
_version_ 1818039289920880640
author Kentaro Jingushi
Toshihisa Nakamura
Fumi Takahashi-Yanaga
Etsuko Matsuzaki
Yutaka Watanabe
Tatsuya Yoshihara
Sachio Morimoto
Toshiyuki Sasaguri
author_facet Kentaro Jingushi
Toshihisa Nakamura
Fumi Takahashi-Yanaga
Etsuko Matsuzaki
Yutaka Watanabe
Tatsuya Yoshihara
Sachio Morimoto
Toshiyuki Sasaguri
author_sort Kentaro Jingushi
collection DOAJ
description Differentiation-inducing factor-1 (DIF-1), a morphogen for Dictyostelium discoideum, inhibits the proliferation of human cancer cell lines by suppressing the Wnt/β-catenin signaling pathway. In this study, we examined the effect of DIF-1 on c-Myc, a target gene product of the Wnt/β-catenin signaling pathway, mainly using HCT-116 colon cancer cells. DIF-1 strongly reduced the amount of c-Myc protein in time- and concentration-dependent manners and reduced c-Myc mRNA expression by inhibiting promoter activity through the TCF binding sites. The effect of DIF-1 on c-Myc was also confirmed using the human cervical cell line HeLa. Pretreatment with the proteasome inhibitor MG132 or glycogen synthase kinase-3β (GSK-3β) inhibitors (LiCl and SB216763) attenuated the effect of DIF-1, suggesting that DIF-1 induced c-Myc protein degradation through GSK-3β activation. Furthermore, we examined whether c-Myc was involved in the anti-proliferative effect of DIF-1 using c-Myc–overexpressing cells and found that c-Myc was associated with the anti-proliferative effect of this compound. These results suggest that DIF-1 inhibits c-Myc expression by inhibiting promoter activity and inducing protein degradation via GSK-3β activation, resulting in the inhibition of cell proliferation. Since c-Myc seems to be profoundly involved in accelerated proliferation of various malignant tumors, DIF-1 may have a potential to develop into a novel anti-cancer agent. Keywords:: c-Myc, Wnt/β-catenin signaling pathway, colon cancer cell, differentiation-inducing factor-1, glycogen synthase kinase-3β
first_indexed 2024-12-10T07:56:16Z
format Article
id doaj.art-90601118b2654fb192711adffd7e4591
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-12-10T07:56:16Z
publishDate 2013-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-90601118b2654fb192711adffd7e45912022-12-22T01:56:53ZengElsevierJournal of Pharmacological Sciences1347-86132013-01-011212103109Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell LinesKentaro Jingushi0Toshihisa Nakamura1Fumi Takahashi-Yanaga2Etsuko Matsuzaki3Yutaka Watanabe4Tatsuya Yoshihara5Sachio Morimoto6Toshiyuki Sasaguri7Department of Clinical Pharmacology, Faculty of Medical Sciences, Periodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Clinical Pharmacology, Faculty of Medical Sciences, Periodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Clinical Pharmacology, Faculty of Medical Sciences, Periodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, Japan; Corresponding author. yanaga@clipharm.med.kyushu-u.ac.jpPeriodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Applied Chemistry, Faculty of Engineering, Ehime University, Matsuyama 790-8577, JapanDepartment of Clinical Pharmacology, Faculty of Medical Sciences, Periodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Clinical Pharmacology, Faculty of Medical Sciences, Periodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Clinical Pharmacology, Faculty of Medical Sciences, Periodontology Section, Division of Oral Rehabilitation, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, JapanDifferentiation-inducing factor-1 (DIF-1), a morphogen for Dictyostelium discoideum, inhibits the proliferation of human cancer cell lines by suppressing the Wnt/β-catenin signaling pathway. In this study, we examined the effect of DIF-1 on c-Myc, a target gene product of the Wnt/β-catenin signaling pathway, mainly using HCT-116 colon cancer cells. DIF-1 strongly reduced the amount of c-Myc protein in time- and concentration-dependent manners and reduced c-Myc mRNA expression by inhibiting promoter activity through the TCF binding sites. The effect of DIF-1 on c-Myc was also confirmed using the human cervical cell line HeLa. Pretreatment with the proteasome inhibitor MG132 or glycogen synthase kinase-3β (GSK-3β) inhibitors (LiCl and SB216763) attenuated the effect of DIF-1, suggesting that DIF-1 induced c-Myc protein degradation through GSK-3β activation. Furthermore, we examined whether c-Myc was involved in the anti-proliferative effect of DIF-1 using c-Myc–overexpressing cells and found that c-Myc was associated with the anti-proliferative effect of this compound. These results suggest that DIF-1 inhibits c-Myc expression by inhibiting promoter activity and inducing protein degradation via GSK-3β activation, resulting in the inhibition of cell proliferation. Since c-Myc seems to be profoundly involved in accelerated proliferation of various malignant tumors, DIF-1 may have a potential to develop into a novel anti-cancer agent. Keywords:: c-Myc, Wnt/β-catenin signaling pathway, colon cancer cell, differentiation-inducing factor-1, glycogen synthase kinase-3βhttp://www.sciencedirect.com/science/article/pii/S1347861319303858
spellingShingle Kentaro Jingushi
Toshihisa Nakamura
Fumi Takahashi-Yanaga
Etsuko Matsuzaki
Yutaka Watanabe
Tatsuya Yoshihara
Sachio Morimoto
Toshiyuki Sasaguri
Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines
Journal of Pharmacological Sciences
title Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines
title_full Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines
title_fullStr Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines
title_full_unstemmed Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines
title_short Differentiation-Inducing Factor-1 Suppresses the Expression of c-Myc in the Human Cancer Cell Lines
title_sort differentiation inducing factor 1 suppresses the expression of c myc in the human cancer cell lines
url http://www.sciencedirect.com/science/article/pii/S1347861319303858
work_keys_str_mv AT kentarojingushi differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT toshihisanakamura differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT fumitakahashiyanaga differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT etsukomatsuzaki differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT yutakawatanabe differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT tatsuyayoshihara differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT sachiomorimoto differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines
AT toshiyukisasaguri differentiationinducingfactor1suppressestheexpressionofcmycinthehumancancercelllines